Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

Alafuzoff, 2006, Interlaboratory comparison of assessments of Alzheimer disease-related lestions: a study of the BrainNet Europe Consortium, J. Neuropathol. Exp. Neurol., 65, 740, 10.1097/01.jnen.0000229986.17548.27

Armitage, 1946, An analysis of certain psychological tests used in the evaluation of brain injury, Psych. Mono., 60, 1

Arriagada, 1992, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease, Neurology, 42, 1681, 10.1212/WNL.42.9.1681

Bennett, 2004, Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function, Arch. Neurol., 61, 378, 10.1001/archneur.61.3.378

Bennett, 2006, Neuropathology of older persons without cognitive impairment from two community-based studies, Neurology, 66, 1837, 10.1212/01.wnl.0000219668.47116.e6

Berg, 1998, Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype, Arch. Neurol., 55, 326, 10.1001/archneur.55.3.326

Berlau, 2007, Dissociation of neuropathological findings and cognition; Case report of an Apolipoprotein E å2/å2 Genotype, Arch. Neurol., 64, 1193, 10.1001/archneur.64.8.1193

Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809

Braak, 1997, Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol. Aging, 18, 351, 10.1016/S0197-4580(97)00056-0

Castellani, 2008, Alzheimer disease pathology as a host response, J. Neuropathol. Exp. Neurol., 67, 523, 10.1097/NEN.0b013e318177eaf4

Crystal, 1988, Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease, Neurology, 38, 1682, 10.1212/WNL.38.11.1682

den Dunnen, 2008, No disease in the brain of a 115 year old woman, Neurobiol. Aging, 29, 1127, 10.1016/j.neurobiolaging.2008.04.010

Dickson, 1992, Identification of normal and pathological aging in prospectively studied nondemented elderly humans, Neurobiol. Aging, 13, 179, 10.1016/0197-4580(92)90027-U

Dickson, 1995, Mismatch between plaques and tangles in staging Alzheimer pathology, Neurobiol. Aging, 16, 283, 10.1016/0197-4580(95)97325-B

Dickson, 2008, Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease, Acta Neuropathol., 115, 437, 10.1007/s00401-008-0345-7

Driscoll, 2006, Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly, Ann. Neurol., 60, 688, 10.1002/ana.21031

Elias, 2000, The preclinical phase of Alzheimer disease. A 22-year prospective study of the Famingham cohort, Arch. Neurol., 57, 808, 10.1001/archneur.57.6.808

Ertekin-Taner, 2008, Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families, Neurology, 70, 596, 10.1212/01.wnl.0000278386.00035.21

Fagan, 2007, Cerebrospinal fluid tau/ß-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults, Arch. Neurol., 64, 343, 10.1001/archneur.64.3.noc60123

Folstein, 1975, Mini-mental state: a practical method for grading the cognitive state of patients for the clinicians, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6

Fotenos, 2008, Brain volume decline in aging: evidence for a relationship between socioeconomic status, preclinical Alzheimer's disease, and reserve, Arch. Neurol., 65, 113, 10.1001/archneurol.2007.27

Galvin, 2005, Predictors of preclinical Alzheimer's disease and dementia: a clinicopathologic study, Arch. Neurol., 62, 758, 10.1001/archneur.62.5.758

Geddes, 1997, Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease, Neurobiol. Aging, 18, S99, 10.1016/S0197-4580(97)00063-8

Goldman, 2001, Absence of cognitive impairment or decline in preclinical Alzheimer's disease, Neurology, 56, 361, 10.1212/WNL.56.3.361

Gomez-Isla, 1996, Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease, J. Neurosci., 16, 4491, 10.1523/JNEUROSCI.16-14-04491.1996

Goodglass, 1983

Haroutunian, 1998, Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease, Arch. Neurol., 55, 1185, 10.1001/archneur.55.9.1185

Haroutunian, 1999, Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease, Arch. Neurol., 56, 713, 10.1001/archneur.56.6.713

Hebert, 2003, Alzheimer disease in the US population, Arch. Neurol., 60, 1119, 10.1001/archneur.60.8.1119

Hulette, 1998, Neuropathological and neuropsychological changes in “normal” aging: evidence for preclinical Alzheimer disease in cognitively normal individuals, J. Neuropathol. Exp. Neurol., 57, 1168, 10.1097/00005072-199812000-00009

Hung, 2008, Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity, J. Neurosci., 28, 11950, 10.1523/JNEUROSCI.3916-08.2008

Iacono, 2008, Neuronal hypertropy in asymptomatic Alzheimer disease, J. Neuropathol. Exp. Neurol., 67, 578, 10.1097/NEN.0b013e3181772794

Katzman, 1988, Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques, Ann. Neurol., 23, 138, 10.1002/ana.410230206

Kawas, 2003, Visual memory predicts Alzheimer's disease more than a decade before diagnosis, Neurology, 60, 1089, 10.1212/01.WNL.0000055813.36504.BF

Khachaturian, 1985, Diagnosis of Alzheimer's disease, Arch. Neurol., 42, 1097, 10.1001/archneur.1985.04060100083029

Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann. Neurol., 55, 306, 10.1002/ana.20009

Knopman, 2003, Neuropathology of cognitively normal elderly, J. Neuropathol. Exp. Neurol., 62, 1087, 10.1093/jnen/62.11.1087

Masliah, 2001, Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease, Neurology, 56, 127, 10.1212/WNL.56.1.127

McKeel, 2004, Neuropathologic criteria for diagnosing Alzheimer Disease in persons with pure dementia of Alzheimer type, J. Neuropathol. Exp. Neurol., 63, 1028, 10.1093/jnen/63.10.1028

Mintun, 2006, [11C] PIB in a nondemented population: potential antecedent marker of Alzheimer disease, Neurology, 67, 446, 10.1212/01.wnl.0000228230.26044.a4

Mirra, 1994, Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), J. Neuropathol. Exp. Neurol., 53, 303, 10.1097/00005072-199405000-00012

Mirra, 1991, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479

Morris, 1993, The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a

Morris, 1996, Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer's disease, Neurology, 46, 707, 10.1212/WNL.46.3.707

1997, Consensus recommendations for the postmortem diagnosis of Alzheimer's disease, Neurobiol. Aging, 18, S1, 10.1016/S0197-4580(97)00057-2

Price, 1991, The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease, Neurobiol. Aging, 12, 295, 10.1016/0197-4580(91)90006-6

Price, 2001, Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease, Arch. Neurol., 58, 1395, 10.1001/archneur.58.9.1395

Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease, Ann. Neurol., 45, 358, 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X

Ray, 2007, Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins, Nat. Med., 13, 1359, 10.1038/nm1653

Riudavets, 2007, Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons, Neurobiol. Aging, 28, 1484, 10.1016/j.neurobiolaging.2007.05.005

Saxton, 2004, Preclinical Alzheimer disease; neuropsychological test performance 1.5 to 8 years prior to onset, Neurology, 63, 2341, 10.1212/01.WNL.0000147470.58328.50

Schmitt, 2000, Preclinical AD revisited. Neuropathology of cognitively normal older adults, Neurology, 55, 370, 10.1212/WNL.55.3.370

Shankar, 2008, Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory, Nat. Med., 837, 10.1038/nm1782

Stern, 2006, Cognitive reserve and Alzheimer disease, Alz. Dis. Assoc. Disord., 20, 112, 10.1097/01.wad.0000213815.20177.19

Tierney, 2005, Neurospsychological tests accurately predict incident Alzheimer disease after 5 and 10 years, Neurology, 64, 1853, 10.1212/01.WNL.0000163773.21794.0B

Tomlinson, 1968, Observations on the brains of non-demented old people, J. Neurol. Sci., 7, 331, 10.1016/0022-510X(68)90154-8

Tomlinson, 1970, Observations on the brains of demented old people, J. Neurol. Sci., 11, 205, 10.1016/0022-510X(70)90063-8

Troncoso, 1998, Neuropathology of preclinical and clinical late-onset Alzheimer's disease, Ann. Neurol., 43, 673, 10.1002/ana.410430519

Troncoso, 1996, Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging, Neurobiol. Aging, 17, 365, 10.1016/0197-4580(96)00028-0

Wechsler, 1987

Wechsler, 1997

West, 2004, Hippocampal neurons in pre-clinical Alzheimer's disease, Neurobiol. Aging, 25, 1205, 10.1016/j.neurobiolaging.2003.12.005